BIOTON S.A. (BIO.WA)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. This filer's financial year end could not be read from its revenue history, so quarters are labelled by the calendar. Amounts in PLN.

Revenue Annual

0 80M 160M 240M 2019: 202M 2020: 221.8M 2021: 163M 2022: 233.2M 2019 2020 2021 2022

Gross Profit Annual

0 40M 80M 120M 2019: 102.2M 2020: 104.7M 2021: 77.8M 2022: 95.8M 2019 2020 2021 2022

Operating Income Annual

0 60M 120M 180M 2019: 163.5M 2020: 48.6M 2021: 14.3M 2022: 21.3M 2019 2020 2021 2022

Net Income Annual

-150M -100M -50M 0 50M 100M 150M 2019: -126.7M 2020: 33.9M 2021: 2.9M 2022: 1.4M 2019 2020 2021 2022

Cost of Revenue Annual

Nothing in this filer's XBRL supports this figure for the periods asked for, so there is nothing to draw. That is a gap in the filing, not a zero.

Operating Cash Flow Annual

0 20M 40M 60M 2019: 46.7M 2020: 41.9M 2021: 5.5M 2022: 56.1M 2019 2020 2021 2022

Free Cash Flow Annual

-15M 0 15M 30M 45M 2019: -6.7M 2020: 37.3M 2021: -7.4M 2022: 26.5M 2019 2020 2021 2022

Operating cash flow minus capital expenditure.

Shares Outstanding Annual

Nothing in this filer's XBRL supports this figure for the periods asked for, so there is nothing to draw. That is a gap in the filing, not a zero.

EPS TTM

Nothing in this filer's XBRL supports this figure for the periods asked for, so there is nothing to draw. That is a gap in the filing, not a zero.